Seasoned pharmaceutical professional with an extensive business development, strategy and financial experiences. Proven deal maker with an excellent reputation, extensive global BD network, exceptional financial and analytical skills, strong scientific background, good business acumen and a determination to drive deals & projects to successful conclusions.
Specialties:Sourcing product or company partnership opportunities. Managing multi-functional due diligence assessments. Conducting market research and estimating commercial potential. Robust financial modeling and analyses to value projects and terms. Developing appropriate positioning and communication strategy. Structuring and negotiating deals. Developing corporate, product or therapeutic area strategies. Assisting early stage companies in business plan preparation, BD projects and financing.
Vice President, Business DevelopmentAmarin Corporation
June 2013 – Present (7 months)Executive Director, Business DevelopmentACEA Biosciences
July 2012 – June 2013 (1 year)|Greater San Diego Area
Head of business development for ACEA Biosciences' Pharmacutical and Technologies business units.
President and FounderRD Consulting, LLC
2011 – 2012 (1 year)|Greater Philadelphia Area
Transaction advisory firm providing business development, strategic and financial consulting support for pharmaceutical, biotech and medical device companies.
Senior Director, Business DevelopmentAuxilium Pharmaceuticals
2004 – 2011 (7 years)Manager, Business DevelopmentTransform Pharmaceuticals
2003 – 2004 (1 year)Senior Associate, Corporate Business DevelopmentEli Lilly and Company
2001 – 2003 (2 years)Senior Research Associate, Pre-Clinical R&DHuman Genome Sciences
1996 – 2000 (4 years)|Washington D.C. Metro Area
BiologistNational Institutes of Health
1993 – 1995 (2 years)|Washington D.C. Metro Area
Thx. Interesting that 1) he's been in the job for seven months (if I read correctly) and nobody has noted or commented; and 2) Thero is now directly involved with partnering issues (according to that section of the company's web site).